Baltimore biotech firm, PathSensors, announced that its CEO, Ted Olsen, joined with other leaders of the Maryland Biohealth community in developing and issuing recommendations to grow Maryland’s biohealth industry and position the state as a globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023.
RM Global has created a VC fund dedicated to the FutuRx biotech incubator Johnson & Johnson set up with OrbiMed and Takeda. The life science investment banking firm has secured preferential access to FutuRx, positioning it to get in on the ground floor alongside the companies that founded the incubator.
Silver Spring drugmaker United Therapeutics Corp. extended an exclusive license with drug giant Eli Lilly & Co. to cover its pulmonary hypertension drug Adcirca, which will lose part of its patent protection later this year.
More people are starting businesses out of opportunity than out of necessity; the percentage of immigrant entrepreneurs is at a two-decade high. However, new businesses are creating fewer jobs than they did a generation ago.
Johns Hopkins University President Ronald J. Daniels will co-chair the steering committee for a new statewide economic development strategy initiative focused on accelerating growth in the life sciences and cybersecurity industries in Maryland, Gov. Larry Hogan announced today.
Maryland’s governor is putting new economic development energy into creating life sciences and cybersecurity startups.
To kick off the Governor’s Business Summit in Baltimore this morning, Gov. Larry Hogan provided some details on Excel Maryland. It’s a new initiative that’s seeking to bring together government, university and the tech community to develop a new strategy to grow startups.
The complex life cycle of a biotechnology product, pharmaceutical or medical device demands a broad range of legal expertise across many practice specialties. From intellectual property protection to corporate and regulatory advice, the leading law firms in the life sciences space combine sophisticated legal counsel with deep scientific knowledge.
Partners HealthCare’s fund to advance innovations made at its hospitals has closed on the last $24.5 million of its most recent funding round.
Pharmaceutical giant Bayer has opened applications for its Grant4Apps programme. Geared to connect health start-ups with industry experts and help the best talents to thrive within the digital healthcare universe, the programme will offer start-ups an opportunity to become part of an economically inclusive market where innovation is not only encouraged but appreciated as a catalyst for expanding both economic and social growth, says Bayer.
We recently joined leaders from across the biomedical ecosystem at the White House to discuss how to best support biomedical innovation that improves human health and creates jobs and opportunity for economic growth. We discussed the unique role of National Institutes of Health-funded academic research in understanding the biology of human disease, and the irreplaceable role of the biotech industry in translating these basic science discoveries into breakthrough therapies for serious human diseases.
